• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Outcomes of re-irradiation & repeat radiotherapy in NSCLC: A propensity matched analysis

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Sandhu, L
    McWilliam, Alan
    Mistry, H.
    Woolf, David K
    Faivre-Finn, Corinne
    Golby, C
    Abravan, Azadeh
    Van Herk, Marcel
    Price, G
    Salem, Ahmed
    Affiliation
    University of Manchester, Division of Cancer Sciences, Manchester,
    Issue Date
    2020
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective Non-small cell lung cancer (NSCLC) locoregional recurrence and second primary are common after (chemo)radiotherapy could be treated with re-irradiation (same area) and repeat radiotherapy (different area), respectively. Our aims were to investigate the outcomes of NSCLC patients treated with re-irradiation and repeat radiotherapy and compare to a matched cohort. Material and Methods NSCLC patients who received two curative-intent thoracic radiotherapy courses in the Christie NHS Foundation Trust (Manchester, UK) [FC(NC1] were retrospectively analysed (2013-2019). Radiotherapy plans were rigidly coregistered, if available, to quantify treatment field overlap and differentiate re-irradiation from repeat radiotherapy. Re-irradiation was designated if >0.5cm3 of the thoracic region received a radiotherapy dose higher than the maximum dose delivered in either of the two radiotherapy plans. A NSCLC patient group who received a single course of curative-intent thoracic radiotherapy was utilized to generate a matched cohort based on age, gender, radiotherapy type (stereotactic ablative radiotherapy (SABR) vs fractionated intensity modulated radiotherapy (IMRT)), TNM stage and ECOG performance score. Logistic regression was used to create a propensity score model. The primary endpoint was overall survival (OS). Results 79 NSCLC patients (median age: 75) underwent two curative-intent thoracic radiotherapy courses (retreatment cohort). The second radiotherapy treatment (RT2) was SABR in 27 and fractionated IMRT in 52 patients. The tumour stage at RT2 was: stage I (n=47), stage II (n=7), stage III (n=7), stage IV (n=3) and unknown (n=15). The median prescribed dose (peaked for SABR) for the RT1 and RT2 was 57Gy (range: 45-88) and 57Gy (range: 54-60), respectively. Table 1 shows characteristics for the retreatment and matched cohort (n=77). The median OS (measured from RT1) for the retreatment cohort was 51m (95% CI: 45-58); fig1A. The median OS was 51m (95%CI: 49- NA) for patients treated with re-irradiation (n=25) and 58m (95%CI: 51-NA) for patients treated with repeat radiotherapy (n=28). After adjusting for lead time bias (OS measured from RT2), patients who underwent retreatment within 1y of the first radiotherapy had worse OS (median: 20m, 95% CI: 12-36) compared to patients where the interradiotherapy gap was >1y (median: 25m, 95% CI: 15-55); p=0.013 (fig1B). The type of radiotherapy and performance score were not prognostic in the retreatment cohort. After adjusting for lead time bias, there was no difference in OS for the retreatment (median: 21m, 95% CI: 15-33) and the matched cohort (median: 22m, 95%CI: 17-NA); p=0.436 Conclusion The lack of survival difference between retreatment and matched cohorts provide indirect evidence of the benefit of a second curative-intent thoracic radiotherapy course in NSCLC patients with locoregional recurrence and second primary. Prospective trials are needed to standardise retreatment dose and investigate toxicity and quality of life.
    Citation
    Sandhu L, McWilliam A, Mistry H, Woolf D, Faivre-Finn C, Golby C, et al. PH-0281: Outcomes of re-irradiation & repeat radiotherapy in NSCLC: A propensity matched analysis. Radiotherapy and Oncology . 2020 Nov;152:S141–2.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/624150
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.